Clinical Trial Update: A Study of Anti-HIV Monoclonal Antibody KD-247 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating KD-247, an anti-HIV monoclonal antibody, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• KD-247

Snippet

Sponsor: The Chemo-Sero-Therapeutic Research Institute | Conditions: HIV Infections | Phase 1 | Status: COMPLETED